Clinical trial
Evaluate Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients.
NCT03088670 is registered in ClinicalTrials.gov with SatRx LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluate Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients.
- Lead sponsor
- SatRx LLC
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 23, 2013
- Completion date
- October 3, 2014
- Enrollment
- 299 (actual)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.